Exablate treatment
Exablate treatment is a medical device with 5 clinical trials. Historical success rate of 80.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
80.0%
4 of 5 finished
20.0%
1 ended early
0
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Study of MRgFUS Exablate Treatment Following the Neuropathic Pain
Study of Exablate Model 4000 Type 1.0/1.1 Following the Treatment of Neuropathic Pain
Parkinson's Disease (PD) Treated With Focused Ultrasound Subthalamotomy at an Early Stage
Study Comparing the Safety and Effectiveness of Magnetic Resonance Guided Focused Ultrasound (MRgFUS) and External Beam Radiation (EBRT) for Treatment of Metastatic Bone Tumors and Multiple Myeloma
Safety and Efficacy of MRgFUS for the Treatment of Low Back Pain
Clinical Trials (5)
Study of MRgFUS Exablate Treatment Following the Neuropathic Pain
Study of Exablate Model 4000 Type 1.0/1.1 Following the Treatment of Neuropathic Pain
Parkinson's Disease (PD) Treated With Focused Ultrasound Subthalamotomy at an Early Stage
Study Comparing the Safety and Effectiveness of Magnetic Resonance Guided Focused Ultrasound (MRgFUS) and External Beam Radiation (EBRT) for Treatment of Metastatic Bone Tumors and Multiple Myeloma
Safety and Efficacy of MRgFUS for the Treatment of Low Back Pain
All 5 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 5